Browsing by Author "Kristiana Siste"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    PublicationMetadata only
    Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    (2021-04-29) Seyed Ramin Radfar; Cornelis A.J. De Jong; Ali Farhoudian; Mohsen Ebrahimi; Parnian Rafei; Mehrnoosh Vahidi; Masud Yunesian; Christos Kouimtsidis; Shalini Arunogiri; Omid Massah; Abbas Deylamizadeh; Kathleen T. Brady; Anja Busse; Marc N. Potenza; Hamed Ekhtiari; Alexander Mario Baldacchino; Adrian Octavian Abagiu; Franck David Noel Abouna; Mohamed Hassan Ahmed; Basma Al-ansari; Feda Mahmmoud Abu Al-khair; Mandhar Humaid Almaqbali; Atul Ambekar; Hossein Mohaddes Ardabili; Sidharth Arya; Victor Olufolahan Lasebikan; Murad Ali Ayasreh; Debasish Basu; Zoubir Benmebarek; Roshan Bhad; Mario Blaise; Nicolas Bonnet; Jennifer Brasch; Barbara Broers; Jenna L. Butner; Moses Camilleri; Giovanna Campello; Giuseppe Carra; Ivan Celic; Fatemeh Chalabianloo; Abhishek Chaturvedi; José de Jesús Eduardo Noyola Cherpitel; Kelly J. Clark; Melissa Anne Cyders; Ernesto de Bernardis; John Edward Derry; Naveen Kumar Dhagudu; Pavla Dolezalova; Geert Dom; Adrian John Dunlop; Mahmoud Mamdouh Elhabiby; Hussien Elkholy; Nsidibe Francis Essien; Ghandi Ilias Farah; Marica Ferri; Georgios D. Floros; Catherine Friedman; Clara Hidalgo Fuderanan; Gilberto Gerra; Abhishek Ghosh; Maka Gogia; Ilias A. Grammatikopoulos; Paolo Grandinetti; Amira Guirguis; David Gutnisky; Paul Steven Haber; Peyman Hassani-Abharian; Zahra Hooshyari; Islam Ibrahim Mokhtar Ibrahim; Hada Fong ha Ieong; Regina Nova Indradewi; Shelly Iskandar; Shobhit Jain; Sandi James; Seyyed Mohammad hossein Javadi; Keun Ho Joe; Darius Jokubonis; Acka Tushevska Jovanova; Rama Mohamed Kamal; Alexander Ivanov Kantchelov; Preethy Kathiresan; Gary Katzman; Paul Kawale; Audrey Margaret Kern; Felix Henrique Paim Kessler; Sung Gon Sue Kim; Ann Marie Kimball; Zeljko Kljucevic; Kristiana Siste; Roneet Lev; Hae Kook Lee; Aiste Lengvenyte; Shaul Lev-ran; Geni Seseja Mabelya; Mohamed Ali El Mahi; J. Maphisa Maphisa; Icro Maremmani; Laura Masferrer; Orlagh McCambridge; Garrett Gregory McGovern; Pusan National University Yangsan Hospital; Iranian National Center for Addiction Studies; College of Medicine, University of Ibadan; Michael G. DeGroote School of Medicine; School of Public Health; School of Advanced Technologies in Medicine; Swansea University Medical School; Surrey and Borders Partnership NHS Foundation Trust; Laureate Institute for Brain Research; The University of Sydney School of Medicine; Pandit Bhagwat Dayal Sharma University of Health Sciences; Melaka-Manipal Medical College, Manipal University; Národní Ústav Duševního Zdraví, Klecany; Psychiatric Hospital Vrap?e; United Nations Office on Drugs and Crime, Austria; University of Social Welfare and Rehabilitation Sciences; Ministry of Health Oman; Université de Yaoundé I; Universitas Padjadjaran; Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo; Vilniaus Universitetas; Al-Ahliyya Amman University; European Monitoring Centre for Drugs and Drug Addiction; Ospedale Santa Chiara Pisa; Haukeland Universitetssjukehus; CUNY School of Medicine; Southern Health and Social Care Trust; Tehran University of Medical Sciences; The University of Sydney; Materials and Energy Research Centre Iran; Indiana University-Purdue University Indianapolis; Medical University of South Carolina; University of Tehran; University of Botswana; Yale School of Medicine; Universiti Malaysia Sabah; Ain Shams University; Radboud Universiteit; Aristotle University of Thessaloniki; Ain Shams University, Faculty of Medicine; Scripps Mercy Hospital; Universiteit Antwerpen; Università degli Studi di Milano-Bicocca; Brown University; Eastern Health; School of Medicine; Hôpitaux Universitaires de Genève; Universitat de Girona; All India Institute of Medical Sciences, New Delhi; Universidade Federal do Rio Grande do Sul; Jane & Terry Semel Institute for Neuroscience & Human Behavior; Tel Aviv University; The Catholic University of Korea; Universidad de Buenos Aires; Mashhad University of Medical Sciences, School of Medicine; The Mount Sinai Medical Center; Postgraduate Institute of Medical Education & Research, Chandigarh; Chatham House; Aġenzija Sedqa; Organization Against Drugs; Addiction medicine clinic; Division for Operations; Addiction Medicine Clinic; Addiction medicine clinic; Addiction medicine clinic; Hayat Center for Treatment and Psycho-social Rehabilitation; National Narcotics Board of Indonesia; SerT Lentini; Serenity Vista Addiction Treatment Center; Addiction Crisis Solutions; Community Health Work; Addiction medicine clinic; Priority Medical Clinic; Israel Center on Addiction; Fuderanan Mental Health Clinic; Sobriety Centers of New Hampshire; Naufar Institute; Al-Amal Psychiatric Hospital; National Center for Mental Health; Georgian Harm Reduction Network; African Institute for Development Policy; ESIC Medical College; Drug and Alcohol Clinical Services; Rebirth Charity Society NGO; Réseau de prévention des addictions (RESPADD); Marmottan Medical Center; Institute for Cognitive Science Studies; Public Health Institute of Split-Dalmatia County; Republican Centre for Addictive Disorders; Heritage Institute of Medical Sciences; Kantchelov Clinic; Center for Research and Information on Substance Abuse; ASL Teramo; National Institute for Infectious Diseases
    Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide, and healthcare systems have reorganized their services in response to the pandemic. Methods: One week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health responses were categorized around (1) managerial measures and systems, (2) logistics, (3) service providers, and (4) vulnerable groups. Results: Respondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. Fifty-seven percent of overdose prevention interventions and 81% of outreach services were also negatively impacted. Conclusions: Participants reported that SUD treatment and harm-reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we highlight several issues and complications resulting from the pandemic concerning people with SUDs that should be tackled more efficiently during the future waves or similar pandemics. The issues and potential strategies comprise the following: (1) helping policymakers to generate business continuity plans, (2) maintaining the use of evidence-based interventions for people with SUDs, (3) being prepared for adequate medication supplies, (4) integrating harm reduction programs with other treatment modalities, and (5) having specific considerations for vulnerable groups such as immigrants and refugees.
  • No Thumbnail Available
    PublicationMetadata only
    Responding to COVID-19: Emerging Practices in Addiction Medicine in 17 Countries
    (2021-03-12) Florian Scheibein; M. J. Stowe; Sidharth Arya; Nirvana Morgan; Tomohiro Shirasaka; Paolo Grandinetti; Noha Ahmed Saad; Abhishek Ghosh; Ramyadarshni Vadivel; Woraphat Ratta-apha; Sagun Ballav Pant; Ramdas Ransing; Rodrigo Ramalho; Angelo Bruschi; Tanay Maiti; Anne Yee HA; Mirjana Delic; Shobhit Jain; Eric Peyron; Kristiana Siste; Joy Onoria; Saïd Boujraf; Lisa Dannatt; Arnt Schellekens; Tanya Calvey; South East Technological University; Faculty of Health Sciences; Pandit Bhagwat Dayal Sharma University of Health Sciences; University of the Witwatersrand Faculty of Health Sciences; Tribhuvan University; Makerere University; Faculté de Médecine et de Pharmacie de Fès, Université Sidi Mohamed Ben Abdellah; Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo; Universiti Malaya; University Psychiatric Hospital; Waikato District Health Board; Ain Shams University; University of the Witwatersrand, Johannesburg; Faculty of Medicine Siriraj Hospital, Mahidol University; All India Institute of Medical Sciences, New Delhi; The University of Auckland; Radboud University Medical Center; University of Cape Town; Postgraduate Institute of Medical Education & Research, Chandigarh; AddiPsy; BKL Walawalkar Rural Medical College; Heritage Institute of Medical Sciences; Teine Keijinkai Medical Center; ASL Teramo; ASL Viterbo